This is a condition where the kidneys don't work properly, specifically the part that filters waste. It causes the kidneys to lose important substances like glucose, amino acids, and phosphate, leading to low potassium levels and acid buildup. It can be inherited or happen later in life. It affects the small tubes in the kidneys.
Every report comes from a Lived member, sent anonymously.
Have you tried Potassium Citrate for Fanconi Syndrome?
Fanconi syndrome is a kidney disorder in which the proximal tubules stop doing one of their main jobs. These tiny tubes are the first stretch of the kidney's filtering units, and they normally reclaim useful substances from filtered fluid and return them to the blood. In Fanconi syndrome, glucose, amino acids, phosphate, bicarbonate, potassium, sodium and uric acid are lost in the urine instead. Those losses explain most of the effects. Losing salt and water leads to large amounts of urine, constant thirst and a tendency to become dehydrated. Losing bicarbonate, the body's main buffer against acid, lets acid build up in the blood. Losing phosphate weakens bones, causing rickets in children and osteomalacia (soft, painful bones that fracture easily) in adults. Low potassium can cause muscle weakness, and children often grow poorly. Fanconi syndrome is a pattern of kidney damage with many possible causes, not a single disease. It is unrelated to Fanconi anemia, an inherited bone marrow disorder that shares the name.
The causes differ by age. In children, Fanconi syndrome is usually part of an inherited metabolic disease. The most common is cystinosis, in which the amino acid cystine builds up inside cells; its kidney effects typically become noticeable between 6 and 18 months of age. Other inherited causes include galactosemia, hereditary fructose intolerance, tyrosinemia, Wilson disease, Lowe syndrome, Fanconi-Bickel syndrome and some mitochondrial disorders. Less often, a gene change affects the tubules alone. In adults, the most common cause is a medicine that damages the tubules. Examples include tenofovir disoproxil fumarate (an older form of tenofovir used for HIV and hepatitis B), the chemotherapy drug ifosfamide, the seizure medicine valproic acid, aminoglycoside antibiotics, the iron-removing drug deferasirox and expired tetracycline. The damage can appear months or even years after a medicine is started, and after ifosfamide it can appear once treatment has ended. The next most common adult cause is a plasma cell disorder (plasma cells are the white blood cells that make antibodies), such as multiple myeloma or a related, milder condition that produces the same abnormal proteins, in which abnormal antibody fragments called light chains injure the tubules. Heavy metals such as lead, cadmium and mercury, amyloidosis and kidney transplant are other causes. Sometimes no cause is found.
The diagnosis rests mainly on urine tests read alongside blood tests. The key clue is a substance appearing in the urine in excess while its level in the blood is normal or low. Glucose in the urine with a normal blood sugar is a classic example: in untreated diabetes, glucose usually spills into the urine because blood levels are high, whereas in Fanconi syndrome the kidney simply fails to hold on to it. Some diabetes, heart and kidney medicines cause glucose in the urine on purpose, so this finding alone does not mean Fanconi syndrome. Urine tests also show extra phosphate, uric acid, amino acids and small proteins. Blood tests often show low phosphate, potassium and uric acid, and low bicarbonate, which signals acid buildup. The next step is finding the cause, because that shapes treatment and outlook. Clinicians review current and past medicines, since stopping a suspected drug and seeing the tubules recover often confirms the diagnosis. Children are assessed for inherited metabolic diseases, which can include genetic testing. Because a plasma cell disorder can be responsible, adults may be tested for abnormal antibody proteins. Kidney function, vitamin D and bone health are usually checked as well.
Treatment has two parts: dealing with the cause where possible, and replacing what the kidneys are losing. If a medicine is responsible, the prescriber will usually stop it or find an alternative. Many cases improve after the drug is withdrawn, though recovery is not always complete. For HIV or hepatitis B, this means switching to another regimen rather than stopping treatment; tenofovir alafenamide, the newer form of tenofovir, is far less often linked to Fanconi syndrome. When a plasma cell disorder is the cause, a hematologist (blood specialist) directs its treatment, but kidney function often does not improve much with it. For cystinosis, cysteamine (Cystagon, or the delayed-release Procysbi) clears cystine from cells. It greatly delays kidney failure and can delay or prevent many of the disease's other complications, but it does not reverse Fanconi syndrome that is already present, so replacement therapy continues alongside it. Replacement therapy is the daily backbone of care. It usually includes plenty of fluids, an alkali such as sodium bicarbonate to correct acid buildup, phosphate and vitamin D to protect bones, and potassium. Correcting acidity matters especially in children, because ongoing acid buildup slows growth. The amounts needed can be large. A thiazide diuretic (a type of water pill) is sometimes added to reduce how much bicarbonate is needed, but both it and bicarbonate can lower potassium, so blood tests guide the doses. If the kidneys eventually fail, dialysis or a kidney transplant becomes necessary.
The outlook depends on the cause. Fanconi syndrome caused by a medicine often settles after the drug is stopped, although some people are left with lasting tubule damage and continue to need supplements. Inherited forms are usually lifelong, and treatment becomes part of the daily routine for the person or family. Ongoing care centers on regular blood and urine tests, usually with a nephrologist (kidney specialist), to adjust supplement doses and watch kidney function over time. In children, growth and bone development are tracked closely, since well-managed replacement therapy helps protect both. Illnesses that cause vomiting or diarrhea can upset the balance quickly, because the body is already losing fluid and minerals through the kidneys. Cystinosis affects more than the kidneys. Without treatment, kidney function begins to decline in early childhood, and cystine crystals can build up in the eyes, causing sensitivity to light, along with hormone problems such as an underactive thyroid. Cysteamine, eye drops made for cystinosis and specialist follow-up aim to slow these changes. With light-chain disease, kidney function can decline over time, so follow-up involves both the kidney and blood specialists.
Arrange an evaluation for a child who passes large amounts of urine, is constantly thirsty, grows poorly or develops bowed legs, or for an adult taking a medicine linked to Fanconi syndrome who develops new bone pain, fractures or unexplained weakness. Routine test results showing glucose in the urine with a normal blood sugar, or low phosphate or potassium, are also worth following up. Contact the care team promptly for signs of dehydration, such as dizziness or a dry mouth; for vomiting or diarrhea that makes it hard to keep down fluids or supplements; or for new or worsening muscle weakness, which can reflect a low potassium or phosphate level. Get emergency care (call 911) for a child or adult who is very drowsy, hard to wake or confused, or who has sudden severe weakness or trouble moving the arms or legs. These can signal severe dehydration or a dangerously low potassium level.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fanconi Syndrome is like, what's helped you, or ask the community a question.